Their findings demonstrated that Factor V Leiden (FVL) homozygosity and antiphospholipid syndrome (APS) antibodies were significantly more prevalent in first-trimester pregnancy losses, illustrating a heightened thrombotic risk early in gestation. The gene discussed is F5; the disease is autoimmune polyendocrinopathy.